Back to Browse Journals » Open Access Journal of Clinical Trials » Volume 4

Is Patch It® better than placebo in alleviating swelling and ache in the lower legs and feet? A randomized, placebo-controlled, double blind, crossover, sequential trial

Authors Shakeel A, Hui HK, Patil CS, Chaudhari MV, Kadam YD, Pensalwar SV, Erande SG, Kewalramani RM

Published Date April 2012 Volume 2012:4 Pages 21—29

DOI http://dx.doi.org/10.2147/OAJCT.S29426

Received 23 December 2011, Accepted 15 February 2012, Published 24 April 2012

Aliya Shakeel1, Hoong Keong Hui2, Chetan S Patil3, Manojkumar V Chaudhari4, Yogesh D Kadam5, Shrikant V Pensalwar6, Suhas G Erande7, Rajesh M Kewalramani8
1Vedic Lifesciences Pvt Ltd, Mumbai, Maharashtra, India; 2Nutriworks Limited, Kowloon, Hong Kong; 3Muktai Hospital, Nasik, 4Bhagirathi Medical Foundation, 5Poona Diabetes Center, 6Balaji Clinic, Mumbai, 7Akshay Hospital, Pune, 8Shanti Niketan, Kandar Pada, Dahisar, Mumbai, Maharashtra, India

Background: Existing therapeutic measures for swelling, aching and discomfort in the lower limbs, which include compression stockings and leg elevation, are difficult to use and inconvenient. Patch It®, a proprietary herbomineral patch is an easy-to-use alternative therapy. This trial was conducted to compare it's efficacy against that of a placebo in swollen and aching lower legs and feet.
Methods: This randomized, placebo-controlled, double blind, crossover, sequential trial was conducted in the private clinics of physicians. A total of 100 patients (24 men and 76 women), aged 25 to 60 years, with recurring swelling in the feet and (optionally) up to two more related complaints, having an average visual analog score (VAS) of at least 60 (scale 0–100) for each complaint were recruited into the study. Patches (active or placebo) were applied to both soles overnight for 8 weeks: 4 consecutive weeks each with active or placebo in randomized sequence. Outcome measures included the average VAS score (baseline to week 4, and week 5 to week 8), preference for either patch (difference of >5 mm in average VAS score reduction), ankle figure-of-eight measures, investigator's global assessment (good, fair, poor), patient's willingness to continue using the patch after the trial (yes, no), and adverse events.
Results: Out of 100 patients, 86 completed the trial, while ten were excluded for noncompliance, three withdrew, and one was lost to follow-up. The active placebo boundary of the sequential chart was crossed when 82 patients completed the trial. Active patch was also superior to placebo patch by mean reductions in average VAS scores (13.14 versus 9.6, P = 0.02), mean reduction in figure-of-eight ankle measurements (1.21 cm versus 0.79 cm, P = 0.003), investigator's global assessment (P < 0.01), and by proportion of patients willing to continue using the patch after the trial (P < 0.01). Ten percent of patients experienced localized itching with each patch, but this did not require interruption of treatment.
Conclusion: Patch It had greater efficacy than the placebo in alleviating recurring swelling and aching in the legs and feet, and is well tolerated.

Keywords: ankle swelling, leg ache, dermal patch, reflexology, sequential analysis, figure-of-eight

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Long-term efficacy of intensive cycle ergometer exercise training program for advanced COPD patients

Pothirat C, Chaiwong W, Phetsuk N, Liwsrisakun C, Bumroongkit C, Deesomchok A, Theerakittikul T, Limsukon A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:133-144

Published Date: 12 January 2015

Knowledge of emergency contraception among students in a tertiary institution in a developing country

Adewunmi AA, Rabiu KA, Tayo AO, Ottun TA, Adeboye BS, Akindele RA

Open Access Journal of Contraception 2012, 3:23-26

Published Date: 16 May 2012

Cell-delivered magnetic nanoparticles caused hyperthermia-mediated increased survival in a murine pancreatic cancer model

Basel MT, Balivada S, Wang H, Shrestha TB, Seo GM, Pyle M, Abayaweera G, Dani R, Koper OB, Tamura M, Chikan V, Bossmann SH, Troyer DL

International Journal of Nanomedicine 2012, 7:297-306

Published Date: 18 January 2012

Long-term effectiveness and safety of sirolimus drug-eluting stents

Bikkina M, Koneru J

Medical Devices: Evidence and Research 2011, 4:117-124

Published Date: 17 August 2011

Optimal management of carpal tunnel syndrome

Shimpei Ono, Philip J Clapham, Kevin C Chung

International Journal of General Medicine 2010, 3:255-261

Published Date: 26 August 2010

Mirror movement associated with neural tube defects

Yasir Andrabi, Farideh Nejat, Mostafa El Khashab, Mohammad Reza Ashrafi

Neuropsychiatric Disease and Treatment 2008, 4:1273-1276

Published Date: 14 September 2008

Kaposiform hemangioendothelioma with distant lymphangiomatosis without an association to Kasabach-Merritt-Syndrome in a female adult!

Claudia S Vetter-Kauczok, Philipp Ströbel, Eva B Bröcker, Jürgen C Becker

Vascular Health and Risk Management 2008, 4:263-266

Published Date: 6 March 2008